Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCash from Financing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Jaguar Health (JAGX) Cash from Operations (2016 - 2025)

Jaguar Health (JAGX) has disclosed Cash from Operations for 11 consecutive years, with 4689000.0 as the latest value for Q3 2025.

  • On a quarterly basis, Cash from Operations rose 26.05% to 4689000.0 in Q3 2025 year-over-year; TTM through Sep 2025 was 26024000.0, a 10.29% increase, with the full-year FY2024 number at 29384000.0, up 11.61% from a year prior.
  • Cash from Operations was 4689000.0 for Q3 2025 at Jaguar Health, up from 6193000.0 in the prior quarter.
  • In the past five years, Cash from Operations ranged from a high of 4689000.0 in Q3 2025 to a low of 10457000.0 in Q2 2022.
  • A 5-year average of 7836736.84 and a median of 7695000.0 in 2022 define the central range for Cash from Operations.
  • Peak YoY movement for Cash from Operations: plummeted 223.12% in 2021, then increased 29.14% in 2024.
  • Jaguar Health's Cash from Operations stood at 8923000.0 in 2021, then rose by 28.02% to 6423000.0 in 2022, then decreased by 16.0% to 7451000.0 in 2023, then fell by 5.03% to 7826000.0 in 2024, then surged by 40.08% to 4689000.0 in 2025.
  • Per Business Quant, the three most recent readings for JAGX's Cash from Operations are 4689000.0 (Q3 2025), 6193000.0 (Q2 2025), and 7316000.0 (Q1 2025).